New data presented by Teva at ECNP 2024* demonstrate switching to UZEDY at four weeks after the last dose of once-monthly Perseris® (RBP-7000) provided the most comparable pharmacokinetic (PK) profile ...
Glioblastoma is an extremely aggressive brain tumour that is currently incurable Cancer doctors can increase their patients life expectancy with surgeries ra ...